Stock TVTX TRAVERE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Travere Therapeutics, Inc.

Equities

TVTX

US89422G1076

Market Closed - Nasdaq
Other stock markets
 21:00:00 24/05/2024 BST 		5-day change 1st Jan Change
6.16 USD -2.84% Intraday chart for Travere Therapeutics, Inc. +1.65% -31.48%
05-15 Transcript : Travere Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM
05-07 Canaccord Genuity Adjusts Price Target on Travere Therapeutics to $18 From $15, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
TRAVERE THERAPEUTICS, INC.
Bio Therapeutic Drugs
-2.84%+1.65%-31.48%-63.29%-67.23% 483M
Bullish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. TVTX Stock
  4. Charts Travere Therapeutics, Inc.
  5. Comparison Chart